May 31, 2017 / 5:13 AM / 2 months ago

BRIEF- Kaken Pharmaceutical to begin sale of Jublia in Korea

1 Min Read

May 31(Reuters) - Kaken Pharmaceutical Co Ltd

* Says its partner company Dong-A ST Co., Ltd. will begin the sale of Jublia, a topical formulation drug for Onychomycosis, in Korea, from June 1

Source text in Japanese:goo.gl/XVfB3P

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below